Estrogen replacement therapy for cognitive benefits: Viable treatment or forgettable "senior moment"?

Heart Disease

Volumn 4, Issue 1, 2002, Pages 26-32

  Marks, Stephen J ^a   Batra, Reema R ^a   Frishman, William H ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; COGNITION; DEMENTIA; ESTROGEN THERAPY; FEMALE; HUMAN; MEDICAL DECISION MAKING; MULTIINFARCT DEMENTIA; NEUROPROTECTION; OVARY DISEASE; PATIENT SELECTION; POSTMENOPAUSE; PREMENOPAUSE; RISK BENEFIT ANALYSIS; TURNER SYNDROME;

EID: 0036274333     PISSN: 1521737X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00132580-200201000-00005     Document Type: Article

References (106)

1. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
2. Postmenopausal hormone therapy and risk of stroke: The Heart and Estrogen-progestin Replacement Study (HERS)
3. Estrogen after ischemic stroke: Effect of estrogen replacement on risk of recurrent stroke and death in the Women's Estrogen for Stroke Trial (WEST)
4. Estrogen effects on cognition in menopausal women
5. Adult age differences in working memory
6. Prevalence of Alzheimer's disease in a community, population of older persons
7. Dynamics of health changes in the oldest old: New perspectives and evidence
8. The influence of ostrogen on the well-being and mental performance in climacteric and postmenopausal women
9. The prevalence of dementia: A quantitative integration of the literature
10. Epidemiology of dementia in a Finnish population
11. Prevalence and incidence of senile and multi-infarct dementia in the Lundby Study: A comparison between the time periods 1947-1957 and 1957-1972
12. Development of dementing illnesses in an 80 year-old volunteer cohort
13. Gender differences in apolipoprotein E-associated risk for familiar Alzheimer disease: A possible clue to higher incidence of Alzheimer disease in women
14. Apolipoprotein E genotype in patient's with Alzheimer's disease: Implications for the risk of dementia among relatives
15. Incidence of dementia and probable Alzheimer's disease in a general population: The Framingham study
16. Effect on gonadal hormones on enzyme activities in brain and pituitary of male and female rats
17. Sex differences in cholinergic enzymes of diagonal band nuclei in the rat preoptic area
18. Use of folliculin in involutional states
19. Menopause consideration of symptoms, etiology and treatment by means of estrogens
20. Roles of steroid hormones and their receptors in structural organization in the nervous system
21. Novel sites and mechanisms of oestrogen action in the brain
22. Autoradiographic localization of estradiol-binding neurons in the rat hippocampal formation and entorhinal cortex
23. The epidemiology of estrogen replacement therapy and Alzheimer's disease
24. Sex-dependent differences in estrogen regulation of choline acetyltransferase are altered by neonatal treatments
25. Estradiol and progesterone regulate neuronal structure and synaptic connectivity in adult as well as developing brain
26. Roles of estradiol and progesterone in estrous cycle in the rat
27. Estradiol selectively regulates agonist binding sites on N-methyl-D-aspartate receptor complex in the CA1 region of the hippocampus
28. Differential regulation of NMDA R1 mRNA and protein by estradiol in the rat hippocampus
29. Estrogen induces synaptic plasticity in adult primate neurons
30. Estrogens as antioxidants
31. Estrogen differentially regulates estrogen and nerve growth factor receptor mRNAs in adult sensory neurons
32. Presumptive estrogen target neurons express mRNAs for both the neurotrophins and neurotrophin receptors: A basis for potential developmental interactions of estrogen with neurotrophins
33. The effect of ovariectomy and estradiol replacement on brain-derived neurotrophic factor messenger ribonucleic acid expression in cortical and hippocampal brain regions of female Sprague-Dawley rats
34. Estrogen regulates metabolism of Alzheimer amyloid β precursor protein
35. Estrogen reduces neuronal generation of Alzheimer β-amyloid peptides
36. L expression and β-amyloid-induced apoptosis: Relevance to Alzheimer's disease
37. The participation of interleukin-6 in the pathogenesis of Alzheimer's disease
38. Hormonal status affects the reactivity of the cerebral vasculature
39. Estrogen increases cerebral and cerebellar blood flows in postmenopausal women
40. Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women
41. Role of estrogens in peripheral and cerebral glucose utilization
42. Estradiol enhances brain glucose update in ovariectomized rats
43. Rat brain serotonin: Biochemical and functional evidence for a sex difference
44. 3H-oestradiol
45. Effects of sex steroids on the development of the locus coeruleus in the rat
46. Effects of estrogen treatment on sensorimotor task performance and brain dopamine concentrations in gonadectomized male and female CD-1 mice
47. Estrogen regulation of dopamine release in the nucleus accumbens: Genomic- and nongenomic-mediated effects
48. Estradiol reduces calcium currents in rat nonsteroidal neurons via a membrane receptor
49. Estrogen affects performance of ovariectomized rats in a two-choice water-escape working memory task
50. Ovarian steroid deprivation results in a reversible learning impairment and compromised cholinergic function in female Sprague-Dawley rats
51. Estrogen improves performance of reinforced T-maze alternation and prevents the amnestic effects of scopolamine administered systemically or intrahippocampally
52. Effects of menstrual cycle on creativity
53. Variations in sex-related cognitive abilities across the menstrual cycle
54. Variations in memory function and sex steroid hormones across the menstrual cycle
55. Use of estrogen in young girls with Turner syndrome. Effects on memory
56. "Add-back" estrogen reverses cognitive deficits induced by a gonadotropin releasing-hormone agonist in women with leiomyomata uteri
57. Role of estrogen deficiency in cognitive function of women with premature ovarian failure
58. Reproductive period and risk of dementia in postmenopausal women
59. Six month study of oestrogen therapy with piperazine oestrone sulphate and its effects on memory
60. Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women
61. Estrogen and cognitive functioning in surgically menopausal women
62. Effects of estrogen on memory function in surgically menopausal women
63. Estrogen use and verbal memory in healthy post-menopausal women
64. Estrogen replacement therapy and memory in older women
65. Enhanced verbal memory in nondemented elderly women receiving hormone-replacement therapy
66. Estrogen improves psychological function in asymptomatic postmenopausal women
67. Estrogen replacement therapy and cognitive function in older women
68. Estrogen therapy in postmenopausal women: Effects on cognitive function and dementia
69. Alzheimer's disease: A study of epidemiological aspects
70. Risk factors for clinically diagnosed Alzheimer's disease: A case-control study of an Italian population
71. A case-control study of Alzheimer's disease in Australia
72. A case-control study of Alzheimer's disease
73. The role of estrogen deficiency in the aging central nervous system
74. Estrogen replacement therapy in older women: Comparisons between Alzheimer's disease cases and non-demented control subjects
75. Lack of postmenopausal estrogen replacement therapy and the risk of dementia
76. Immunological and endocrine conditions in an Alzheimer's disease case-control study
77. Estrogen replacement therapy may protect against intellectual decline in postmenopausal women
78. Estrogen replacement therapy and risk of Alzheimer's disease
79. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: The Baltimore longitudinal study of aging
80. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease
81. Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease: A population-based case-control study
82. Postmenopausal estrogen replacement therapy and risk of AD: A population-based study
83. Estrogen-replacement therapy and Alzheimer's disease in the Italian longitudinal study on aging
84. Hormone replacement therapy and condition. Systematic review and meta-analysis
85. Cognitive function in postmenopausal women treated with raloxifene
86. Can estrogen or selective estrogen-receptor modulators preserve cognitive function in elderly women?
87. Preliminary assessment of cognitive function in breast cancer patients treated with tamoxifen
88. An evaluation of psychological effects of sex hormone administration in aged women
89. Estrogen for older women
90. Effects of estrogen replacement therapy on cerebral perfusion and cognition among postmenopausal women
91. An effect of conjugated estrogen to cognitive impairment in women with senile dementia-Alzheimer's type: A placebo-controlled double blind study
92. The role of estrogen in the treatment of Alzheimer's disease
93. Cognitive and neuroendocrine response to transdermal estrogen in postmenopausal women with Alzheimer's disease: Results of a placebo-controlled, double-blind, pilot study
94. Estrogens in the pathogenesis and treatment of Alzheimer's disease in postmenopausal women
95. Observations in a preliminary open trial of estradiol therapy for senile dementia (Alzheimer's type)
96. In vivo effects by estrone sulfate on the central nervous system-senile dementia (Alzheimer's type)
97. Long-term estrogen replacement therapy in female patients with dementia of the Alzheimer type: 7 Case reports
98. Evaluation of estrogen treatment in female patients with dementia of the Alzheimer type
99. Cognitive skills associated with estrogen replacement in women with Alzheimer's disease
100. Effects of estrogen replacement therapy in response to tacrine in patients with Alzheimer's disease
101. Estrogen for Alzheimer's disease in women: Randomized, double-blind, placebo-controlled trial
102. Estrogen replacement therapy for treatment of mild to moderate Alzheimer's disease: A 1-year randomized controlled trial
103. Effects of estrogen on cognition, mood and cerebral blood flow in AD: A controlled study
104. Hormone replacement therapy and breast cancer: Revisiting the issues
105. Indications zur hormonsatz-therapei
106. Ovarian steroids and the brain: Implications for cognition and aging